NextGen
www.nextgensciences.comSymbol: NGG.L
Currently trading at: 0.065p UP 0.005
NextGen Sciences Ltd is the primary operating arm of listed NextGen Group plc. It provides technologies and reagents for molecular biology and protein research. The company’s advanced products automate and simplify complex research techniques, saving time and resources, improving results and accelerating discovery.
NextGen Sciences was established in May 2000 by cofounders Dr Kevin Auton and David Wigley, Director of Operations, to address the protein research market. Since foundation, the company has evolved to become a leading provider of integrated solutions for protein research.
The parent company listed on the London Stock Exchange (AIM market) in early 2006.
Following a review of strategy, it relocated its Head Office to Michigan in late 2007 and now is focussed on biomarker services (discovery, assay development and testing) for pharmaceutical and biotechnology customers.
Staff
 David Wigley MBA, Director of Operations and co-founderMr Wigley has a wide range of project management, IT systems and manufacturing experience gained in companies including the Mars Corporation, Cambridge Systems Technology, as a manufacturing consultant, and in his role as operations director at Anglia Business Computers where he was a board member. Mr Wigley has extensive expertise in all aspects of operations and project planning relevant to NextGen Sciences' business and his expertise has enabled the company to take products from concept to design to production in the shortest possible times. Mr Wigley’s first degree is in Physics from the University of Nottingham. |
Contact details
Alconbury North Airfield
Alconbury
Huntingdon
Cambridgeshire
PE28 4DA
United Kingdom
t: +44 (0) 1480 410 850
f: +44 (0) 1480 410 858
